Healthcare stocks are narrowly mixed with NYSE Healthcare Sector index climbing 0.2% while shares of healthcare companies in the S&P 500 are down a combined 0.2%.
In company news, General Electric ( GE ) is down 0.4% in late trade at $25.83 a share, or just 3 cents above its session low despite its GE Healthcare unit confirms FDA approval of its Vizamyl radioactive injection to detect beta amyloids in the brains of people at risk of Alzheimer's disease.
Vizamyl is the only imaging tracer approved for use with positron emission tomography (PET) imaging and allowing for visual interpretation of color images rather than black and white assessments. It is expected to be commercially available in 2014.
In other sector news,
(+) EHTH, Q3 earnings of $0.08 per share, ex items, match Capital IQ consensus. Revenue rises 11.8% year over year to $42 mln, beating estimates by $1.54 mln. Reaffirms in-line FY13 EPS guidance of $0.61 to $ 0.71 per share on $168 mln to $174 mln in sales.
(-) HWAY, Reports Q3 net income and revenue that missed analyst expectations and cutting its Q4 outlook. Also forecasts FY14 revenue trailing analyst analyst expectations by at least $40.67 million.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.